These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Antibiotic stewardship challenges in the management of community-acquired infections for prevention of escalating antibiotic resistance. Garau J; Nicolau DP; Wullt B; Bassetti M J Glob Antimicrob Resist; 2014 Dec; 2(4):245-253. PubMed ID: 27873683 [TBL] [Abstract][Full Text] [Related]
47. Antibiotic stewardship programmes in intensive care units: Why, how, and where are they leading us. Zhang YZ; Singh S World J Crit Care Med; 2015 Feb; 4(1):13-28. PubMed ID: 25685719 [TBL] [Abstract][Full Text] [Related]
48. Antibiotics for ventilator-associated pneumonia. Arthur LE; Kizor RS; Selim AG; van Driel ML; Seoane L Cochrane Database Syst Rev; 2016 Oct; 10(10):CD004267. PubMed ID: 27763732 [TBL] [Abstract][Full Text] [Related]
49. Nano-Strategies to Fight Multidrug Resistant Bacteria-"A Battle of the Titans". Baptista PV; McCusker MP; Carvalho A; Ferreira DA; Mohan NM; Martins M; Fernandes AR Front Microbiol; 2018; 9():1441. PubMed ID: 30013539 [TBL] [Abstract][Full Text] [Related]
50. The antimicrobial resistance crisis: causes, consequences, and management. Michael CA; Dominey-Howes D; Labbate M Front Public Health; 2014; 2():145. PubMed ID: 25279369 [TBL] [Abstract][Full Text] [Related]
51. Validation of Selective Agars for Detection and Quantification of Escherichia coli Strains Resistant to Critically Important Antimicrobials. Lee ZZ; Abraham R; O'Dea M; Harb A; Hunt K; Lee T; Abraham S; Jordan D Microbiol Spectr; 2021 Dec; 9(3):e0066421. PubMed ID: 34756091 [TBL] [Abstract][Full Text] [Related]
52. Implementation of the World Health Organization Global Antimicrobial Resistance Surveillance System in Uganda, 2015-2020: Mixed-Methods Study Using National Surveillance Data. Nabadda S; Kakooza F; Kiggundu R; Walwema R; Bazira J; Mayito J; Mugerwa I; Sekamatte M; Kambugu A; Lamorde M; Kajumbula H; Mwebasa H JMIR Public Health Surveill; 2021 Oct; 7(10):e29954. PubMed ID: 34673531 [TBL] [Abstract][Full Text] [Related]
53. Circumventing antimicrobial-resistance and preventing its development in novel, bacterial infection-control strategies. Yu T; Jiang G; Gao R; Chen G; Ren Y; Liu J; van der Mei HC; Busscher HJ Expert Opin Drug Deliv; 2020 Aug; 17(8):1151-1164. PubMed ID: 32510243 [TBL] [Abstract][Full Text] [Related]
54. Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal. Tarín-Pelló A; Suay-García B; Pérez-Gracia MT Expert Rev Anti Infect Ther; 2022 Aug; 20(8):1095-1108. PubMed ID: 35576494 [TBL] [Abstract][Full Text] [Related]
58. Antibiotic rotation strategies to reduce antimicrobial resistance in Gram-negative bacteria in European intensive care units: study protocol for a cluster-randomized crossover controlled trial. van Duijn PJ; Bonten MJ Trials; 2014 Jul; 15():277. PubMed ID: 25011604 [TBL] [Abstract][Full Text] [Related]
59. Antimicrobial stewardship - can we afford to do without it? Aryee A; Price N Br J Clin Pharmacol; 2015 Feb; 79(2):173-81. PubMed ID: 24803175 [TBL] [Abstract][Full Text] [Related]
60. Antibiotic Discovery and Resistance: The Chase and the Race. Iskandar K; Murugaiyan J; Hammoudi Halat D; Hage SE; Chibabhai V; Adukkadukkam S; Roques C; Molinier L; Salameh P; Van Dongen M Antibiotics (Basel); 2022 Jan; 11(2):. PubMed ID: 35203785 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]